Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory Kirk

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Journal of the International AIDS Society|April 16, 2020
Weight gain among treatment-naïve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and CanadaKassem Bourgi, Cathy A Jenkins, Peter F Rebeiro, et al.
Plos One|December 25, 2013
Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and CanadaHasina Samji, Angela Cescon, Robert S Hogg, et al.
Science Immunology|November 11, 2018
Inhibitory killer cell immunoglobulin-like receptors strengthen CD8<sup>+</sup> T cell-mediated control of HIV-1, HCV, and HTLV-1Lies Boelen, Bisrat Debebe, Marcos Silveira, et al.
Journal of Virology|November 24, 2017
Differential Immunodominance Hierarchy of CD8<sup>+</sup> T-Cell Responses in HLA-B*27:05- and -B*27:02-Mediated Control of HIV-1 InfectionEmily Adland, Matilda Hill, Nora Lavandier, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Journal of the International AIDS Society|April 16, 2020
Weight gain among treatment-naïve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and CanadaKassem Bourgi, Cathy A Jenkins, Peter F Rebeiro, et al.
Plos One|December 25, 2013
Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and CanadaHasina Samji, Angela Cescon, Robert S Hogg, et al.
Science Immunology|November 11, 2018
Inhibitory killer cell immunoglobulin-like receptors strengthen CD8<sup>+</sup> T cell-mediated control of HIV-1, HCV, and HTLV-1Lies Boelen, Bisrat Debebe, Marcos Silveira, et al.
Journal of Virology|November 24, 2017
Differential Immunodominance Hierarchy of CD8<sup>+</sup> T-Cell Responses in HLA-B*27:05- and -B*27:02-Mediated Control of HIV-1 InfectionEmily Adland, Matilda Hill, Nora Lavandier, et al.
Pageof 3